PAPER Farlow M, Anand R, Messina J, Hartman R, Veach J

A 52-week study of the efficacy of rivastigmine in patients with mild to moderately severe Alzheimer's disease.

Eur Neurol. 2000;44(4):236-41. PubMed.

PAPER Mokliatchouk O, Blacker D, Rabinowitz D

Association tests for traits with variable age at onset.

Hum Hered. 2001;51(1-2):46-53. PubMed.

PAPER Kittler L, Wollweber L

Down-regulation of H tau 40 protein expression by minor groove binders.

Nucleosides Nucleotides Nucleic Acids. 2000 Aug;19(8):1241-8. PubMed.

PAPER Gauthier E, Fortier I, Courchesne F, Pepin P, Mortimer J, Gauvreau D

Aluminum forms in drinking water and risk of Alzheimer's disease.

Environ Res. 2000 Nov;84(3):234-46. PubMed.

PAPER Adamec E, Mohan PS, Cataldo AM, Vonsattel JP, Nixon RA

Up-regulation of the lysosomal system in experimental models of neuronal injury: implications for Alzheimer's disease.

Neuroscience. 2000;100(3):663-75. PubMed.

PAPER Amouyal-Barkate K, Bagheri-Charabiani H, Montastruc JL, Moulias S, Vellas B

Abnormal movements with donepezil in Alzheimer disease.

Ann Pharmacother. 2000 Nov;34(11):1347. PubMed.

PAPER Lee JM

Alzheimer disease

Arch Pathol Lab Med. 2000 Dec;124(12):1851. PubMed.

PAPER Camps P, El Achab R, Morral J, Muñoz-Torrero D, Badia A, Baños JE, Vivas NM, Barril X, Orozco M, Luque FJ

New tacrine-huperzine A hybrids (huprines): highly potent tight-binding acetylcholinesterase inhibitors of interest for the treatment of Alzheimer's disease.

J Med Chem. 2000 Nov 30;43(24):4657-66. PubMed.

PAPER Singleton AB, Hall R, Ballard CG, Perry RH, Xuereb JH, Rubinsztein DC, Tysoe C, Matthews P, Cordell B, Kumar-Singh S, De Jonghe C, Cruts M, Van Broeckhoven C, Morris CM

Pathology of early-onset Alzheimer's disease cases bearing the Thr113-114ins presenilin-1 mutation.

Brain. 2000 Dec;123 Pt 12:2467-74. PubMed.

PAPER Haugabook SJ, Le T, Yager D, Zenk B, Healy BM, Eckman EA, Prada C, Younkin L, Murphy P, Pinnix I, Onstead L, Sambamurti K, Golde TE, Dickson D, Younkin SG, Eckman CB

Reduction of Abeta accumulation in the Tg2576 animal model of Alzheimer's disease after oral administration of the phosphatidyl-inositol kinase inhibitor wortmannin.

FASEB J. 2001 Jan;15(1):16-18. Epub 2000 Nov 9 PubMed.

PAPER Hu CJ, Sung SM, Liu HC, Hsu WC, Lee LS, Lee CC, Tsai CH, Chang JG

Genetic risk factors of sporadic Alzheimer's disease among Chinese in Taiwan.

J Neurol Sci. 2000 Dec 1;181(1-2):127-31. PubMed.

PAPER Labar KS, Mesulam M, Gitelman DR, Weintraub S

Emotional curiosity: modulation of visuospatial attention by arousal is preserved in aging and early-stage Alzheimer's disease.

Neuropsychologia. 2000;38(13):1734-40. PubMed.

PAPER Derouesné C, Lagha-Pierucci S, Thibault S, Baudouin-Madec V, Lacomblez L

Apraxic disturbances in patients with mild to moderate Alzheimer's disease.

Neuropsychologia. 2000;38(13):1760-9. PubMed.

PAPER Pakaski M, Rakonczay Z, Kasa P

Reversible and irreversible acetylcholinesterase inhibitors cause changes in neuronal amyloid precursor protein processing and protein kinase C level in vitro.

Neurochem Int. 2001 Mar;38(3):219-26. PubMed.

PAPER Guénette SY, Bertram L, Crystal A, Bakondi B, Hyman BT, Rebeck GW, Tanzi RE, Blacker D

Evidence against association of the FE65 gene (APBB1) intron 13 polymorphism in Alzheimer's patients.

Neurosci Lett. 2000 Dec 15;296(1):17-20. PubMed.